Home Featured Page 228

Featured

Latest

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a...

Filament Health Files 20th Patent Application Including Three International PCT Applications

What Is the ‘Collective Unconscious’ and How Can It Help Us...

Comparing Psilocybin Mushrooms and Truffles: How Are They Different?

PT260 – Benjamin Mudge – Ayahuasca and Bipolar: Pathways to a...

Red Light Holland and Creso Pharma Agree to Terminate Merger

Biotech Veteran David Kideckel Joins the Board of PharmaDrug

Psychedelic Bulletin: California Decrim. Bill Put on Pause; MindMed Inks Real-World...

Small Pharma Announces Appointment of Lyne Fortin as Chair of the...

PTSF74 – A Response: Decriminalize Nature, SB-519, and MAPS

1...227228229...304 Page 228 of 304

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

The Psychedelic News Feed: December 1 – 7, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a...

Filament Health Files 20th Patent Application Including Three International PCT Applications

What Is the ‘Collective Unconscious’ and How Can It Help Us...

Comparing Psilocybin Mushrooms and Truffles: How Are They Different?

PT260 – Benjamin Mudge – Ayahuasca and Bipolar: Pathways to a...

Red Light Holland and Creso Pharma Agree to Terminate Merger

Biotech Veteran David Kideckel Joins the Board of PharmaDrug

Psychedelic Bulletin: California Decrim. Bill Put on Pause; MindMed Inks Real-World...

Small Pharma Announces Appointment of Lyne Fortin as Chair of the...

PTSF74 – A Response: Decriminalize Nature, SB-519, and MAPS

EDITOR PICKS

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

The Psychedelic News Feed: December 1 – 7, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY